Issue 30
Get instant access to latest e-book

latest news


May 2018

mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States

mAbxience a company specialized in the research development manufacturing and global commercialization of monoclonal antibody biosimilars part of the Insud Pharma Group and Amneal Pharmaceuticals Inc NYSE AMRX an integrated specialty pharmaceutical company powered by a robust US generics business have signed an exclusive licensing…


May 2018

CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease

CENTOGENE the worldwide leader in elucidating rare disease genetics for patients clinicians and pharmaceutical partners today announced a clinical development collaboration with Orphazyme AS CPH ORPHA to improve the lives of patients and families living with neuronopathic Gaucher disease a rare inherited progressive and debilitating…


May 2018

Eurofins Expands Its Biopharmaceutical Products Testing Footprint with an Outsourcing Agreement with Astellas in Japan

Eurofins Scientific a global leader in biopharmaceutical products testing services announces that it has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories Astellas Analytical Science Laboratories Inc ASL ASL was established in as the core pharmaceutical product testing provider…

press releases


May 2018

Impact India Foundation’s Lifeline Express treats 12lakh lives since inception

Business Wire IndiaImpact India Foundation is best known for the worlds first hospital train the LIFELINE EXPRESS LLE which was launched in and runs on a broadgauge railway track The…


May 2018

Otsuka and Lundbeck to Start Third Phase 3 Trial in June to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Alzheimer's Disease

Otsuka Pharmaceutical Company Ltd Otsuka and Lundbeck announce that the two companies third clinical Phase study of brexpiprazole in the treatment of agitation in patients with dementia of the Alzheimers…


May 2018

FDA Grants Breakthrough Therapy Designation for Tafamidis for the Treatment of Patients with Transthyretin Cardiomyopathy

Pfizer Inc announced today that tafamidis received Breakthrough Therapy designation from the US Food and Drug Administration FDA for the treatment of patients with transthyretin cardiomyopathy a rare fatal and…

Events


May 2018

T3: Trials, Tech and Transformation

KNect365 Life Sciences
Raleigh Convention Center


Jun 2018

Pre-Filled Syringes West Coast conference

SMi Group
Crowne Plaza San Diego


  • 2

    Cancer Stem Cell (CSC) Inhibitors

    Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..

Knowledge Bank

Editorial Section

  • Strategy


    As the pharmaceutical industry squares off against the challenge of globalisation there is a greater need for content than ever Driven by forces from both the clinical and commercial sides pharmaceutical companies are experiencing rising costs and competition Ultimately to…

  • Research development

    Knowing vs Hunting for Targets

    Selecting a target for settingup the drug discovery path is a tough decision and often this choice is based on borrowed and incomplete knowledge from the literature In many cases this has led to serious challenges in the late stages…

  • Clinical Trials

    Use of Real World Evidence

    Real World Evidence RWE can be used to inform decisions throughout the life cycle of a drug from development through postapproval Across Asia many countries have begun incorporating real world evidence and while some are fast adopters in terms of…

  • Manufacturing

    Cultural Excellence as the Foundation

    In pharmaceutical companies it is universally understood that a robust Pharmaceutical Quality System PQS provides key elements of assurance and oversight for pharmaceutical manufacturing and quality control laboratory processes However despite recent advances in the…

  • Expert Talk

    Pushing the Limits of Temperature Control

    Todays pharmaceutical environment has become increasingly complex with more specialty products like biologics injectable and clinical trial drugs being shipped than ever The industry standard for commercial packaging is hours which is no longer always…